Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 11/2023

02.08.2023 | Original Paper

External validation of the unifying concept for the quantitative assessment of functional mitral regurgitation

verfasst von: Pedro M. Lopes, Francisco Albuquerque, Pedro Freitas, Carla Reis, Sara Guerreiro, João Abecasis, Marisa Trabulo, António M. Ferreira, Regina Ribeiras, Miguel Mendes, Maria J. Andrade

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A novel conceptual framework was introduced to enhance the quantitative assessment of functional mitral regurgitation (FMR) and improve risk stratification. However, the data was derived from a single-center cohort and lack external validation. We aimed to validate the proposed algorithm using a different patient population.

Methods

Patients with at least mild FMR and reduced left ventricular ejection fraction (< 50%) were retrospectively identified at a single-center. The cohort was stratified in low, intermediate and high-risk according to the proposed framework, on the basis of effective regurgitant orifice area (EROA) and regurgitant volume (RegVol). Patients within the intermediate-risk group were subsequently reclassified into either the low-risk category (Regurgitant Fraction, RegFrac < 50%) or the high-risk category (RegFrac ≥ 50%) based on their regurgitant fraction. The primary endpoint was all-cause mortality.

Results

A total of 572 patients were included. During a median follow-up of 3.8 years there were 254 deaths (44%). On multivariable analysis, the proposed thresholds for FMR severity remained independently associated with all-cause mortality (adjusted hazard ratio: 1.488; 95% confidence interval [CI]: 1.110–2.013; p-value = 0.010). This algorithm demonstrated superior discriminative ability (C-statistic: 0.664) compared to contemporary guidelines (C-statistic: 0.522; p-value for comparison < 0.001). Additionally, it resulted in a significant improvement in the net reclassification index (0.162; p-value < 0.001).

Conclusions

Within our cohort, the application of the proposed concept demonstrated a significant association with a higher risk of all-cause mortality. Moreover, this conceptual framework showcased the potential to improve the accuracy of risk prediction beyond current guidelines.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43(7):561–632CrossRefPubMed Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43(7):561–632CrossRefPubMed
2.
Zurück zum Zitat Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al (2021) 2020 ACC/AHA Guideline for the management of patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4):e25–197CrossRefPubMed Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al (2021) 2020 ACC/AHA Guideline for the management of patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4):e25–197CrossRefPubMed
3.
Zurück zum Zitat Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ et al (2016) Two-year outcomes of Surgical Treatment of Moderate ischemic mitral regurgitation. N Engl J Med 374(20):1932–1941CrossRefPubMedPubMedCentral Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ et al (2016) Two-year outcomes of Surgical Treatment of Moderate ischemic mitral regurgitation. N Engl J Med 374(20):1932–1941CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Obadia J-F, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N et al (2018) Percutaneous Repair or Medical Treatment for secondary mitral regurgitation. N Engl J Med 379(24):2297–2306CrossRefPubMed Obadia J-F, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N et al (2018) Percutaneous Repair or Medical Treatment for secondary mitral regurgitation. N Engl J Med 379(24):2297–2306CrossRefPubMed
5.
Zurück zum Zitat Bartko PE, Arfsten H, Heitzinger G, Pavo N, Toma A, Strunk G et al (2019) A Unifying Concept for the quantitative Assessment of secondary mitral regurgitation. J Am Coll Cardiol 73(20):2506–2517CrossRefPubMed Bartko PE, Arfsten H, Heitzinger G, Pavo N, Toma A, Strunk G et al (2019) A Unifying Concept for the quantitative Assessment of secondary mitral regurgitation. J Am Coll Cardiol 73(20):2506–2517CrossRefPubMed
6.
Zurück zum Zitat McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726CrossRefPubMed McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726CrossRefPubMed
7.
Zurück zum Zitat Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA Guideline for the management of heart failure. J Am Coll Cardiol. ;79(17) Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA Guideline for the management of heart failure. J Am Coll Cardiol. ;79(17)
8.
Zurück zum Zitat Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA et al (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular magnetic resonance. J Am Soc Echocardiogr 30(4):303–371CrossRefPubMed Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA et al (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular magnetic resonance. J Am Soc Echocardiogr 30(4):303–371CrossRefPubMed
9.
Zurück zum Zitat Heagerty PJ (2000) Compute time-dependent ROC curve from censored survival data using Kaplan-Meier (KM) or nearest neighbor estimation (NNE) method. Biometrics 56(2):337–344CrossRefPubMed Heagerty PJ (2000) Compute time-dependent ROC curve from censored survival data using Kaplan-Meier (KM) or nearest neighbor estimation (NNE) method. Biometrics 56(2):337–344CrossRefPubMed
10.
Zurück zum Zitat Bartko PE, Hülsmann M, Goliasch G (2018) Quantitative definition of severe functional mitral regurgitation. J Am Coll Cardiol 72(23):2934–2935CrossRefPubMed Bartko PE, Hülsmann M, Goliasch G (2018) Quantitative definition of severe functional mitral regurgitation. J Am Coll Cardiol 72(23):2934–2935CrossRefPubMed
11.
Zurück zum Zitat Grayburn PA, Carabello B, Hung J, Gillam LD, Liang D, Mack MJ et al (2014) Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol 64(25):2792–2801CrossRefPubMed Grayburn PA, Carabello B, Hung J, Gillam LD, Liang D, Mack MJ et al (2014) Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol 64(25):2792–2801CrossRefPubMed
12.
Zurück zum Zitat Marwick TH, Zoghbi WA, Narula J (2014) Redrawing the borders: considering guideline revision in functional mitral regurgitation. JACC Cardiovasc Imaging 7(3):333–335CrossRefPubMed Marwick TH, Zoghbi WA, Narula J (2014) Redrawing the borders: considering guideline revision in functional mitral regurgitation. JACC Cardiovasc Imaging 7(3):333–335CrossRefPubMed
13.
Zurück zum Zitat Grayburn PA, Sannino A, Packer M (2019) Proportionate and disproportionate functional mitral regurgitation: a new conceptual Framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 12(2):353–362CrossRefPubMed Grayburn PA, Sannino A, Packer M (2019) Proportionate and disproportionate functional mitral regurgitation: a new conceptual Framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 12(2):353–362CrossRefPubMed
14.
Zurück zum Zitat Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379(24):2307–2318CrossRefPubMed Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379(24):2307–2318CrossRefPubMed
15.
Zurück zum Zitat Lopes PM, Albuquerque F, Freitas P, Gama F, Horta E, Reis C et al (2021) Assessing proportionate and disproportionate functional mitral regurgitation with individualized thresholds. Eur Hear J - Cardiovasc Imaging 351:1–10 Lopes PM, Albuquerque F, Freitas P, Gama F, Horta E, Reis C et al (2021) Assessing proportionate and disproportionate functional mitral regurgitation with individualized thresholds. Eur Hear J - Cardiovasc Imaging 351:1–10
16.
Zurück zum Zitat Benfari G, Antoine C, Essayagh B, Batista R, Maalouf J, Rossi A et al (2021) Functional mitral regurgitation outcome and grading in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging 14(12):2303–2315CrossRefPubMed Benfari G, Antoine C, Essayagh B, Batista R, Maalouf J, Rossi A et al (2021) Functional mitral regurgitation outcome and grading in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging 14(12):2303–2315CrossRefPubMed
Metadaten
Titel
External validation of the unifying concept for the quantitative assessment of functional mitral regurgitation
verfasst von
Pedro M. Lopes
Francisco Albuquerque
Pedro Freitas
Carla Reis
Sara Guerreiro
João Abecasis
Marisa Trabulo
António M. Ferreira
Regina Ribeiras
Miguel Mendes
Maria J. Andrade
Publikationsdatum
02.08.2023
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 11/2023
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-023-02920-z

Weitere Artikel der Ausgabe 11/2023

The International Journal of Cardiovascular Imaging 11/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.